MTAMTech Corporation, a technology spin-off of Taipei Medical University. Established in 2016 with Professor Chen and a team of highly specialized technical members, we established our office at the Nangang Biotech Incubation Center. We strive to develop next generation anti-cancer drug screening solutions that fits your needs as a patient and/or as a drug developer by offering the greatest solution with significant value propositions regardless of segment.
Over the years, we have grown to become a solid company with significant scientific and clinical backing with multiple publications within these field. More recent developments are centered around the application of the MTAM-HFA in Immuno-Checkpoint Blockers (ICBs) either in combination therapy; and yes that includes non-drug combinations such as irradiation and etc.
Core Team Members